Paradigm Biopharmaceuticals LtdHere is the public summary page for Paradigm Biopharmaceuticals Ltd. Please login to see the complete information for Paradigm Biopharmaceuticals Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Paradigm Biopharmaceuticals Ltd stacks up relative to its peers. |
| Darwin Score | +13 |
| Ticker | PAR |
| Latest Price | 0.35 AUD as of close on 01-Aug-2025 |
| 3 Month price range | 0.28 to 0.47 AUD |
| Market Capitalisation | 184.80Mn AUD |
| Country | Australia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. See More ... |
| Company URL | https://www.paradigmbiopharma.com |
| See Darwins Full Analysis for Paradigm Biopharmaceuticals Ltd |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Paradigm Biopharmaceuticals Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +27 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -2 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -11 |
Peer Comparison
There are 11 peers of Paradigm Biopharmaceuticals Ltd.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | +7 |
| BTC Health Ltd (BTC) | Biotechnology | +27 |
| CSL Ltd (CSL) | Biotechnology | +12 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | -19 |
| Imugene Ltd (IMU) | Biotechnology | -10 |
| Mesoblast Ltd (MSB) | Biotechnology | -8 |
| Opthea Ltd (OPT) | Biotechnology | -13 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +27 |
| Polynovo Ltd (PNV) | Biotechnology | -2 |
| Race Oncology Ltd (RAC) | Biotechnology | 0 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | +1 |
Share 
